Application 202155
- Type
- NDA
- Sponsor
- BRISTOL MYERS SQUIBB
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ELIQUIS | APIXABAN | TABLET;ORAL | 2.5MG | Yes | No |
| 002 | ELIQUIS | APIXABAN | TABLET;ORAL | 5MG | Yes | Yes |
| 003 | ELIQUIS | APIXABAN | TABLET, FOR SUSPENSION;ORAL | 0.5MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0893 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-0894 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3764 | ELIQUIS | apixaban | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 50090-1436 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1436 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1436 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1436 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1436 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1437 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1437 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 50090-1437 | ELIQUIS | apixaban | A-S Medication Solutions | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0612 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health | NDA | Current |
| 55154-0613 | ELIQUIS | apixaban | Cardinal Health 107, LLC | NDA | Current |